Biomaterials are widely used in medical devices, tissue replacements, and surface coating applications. These materials are used in the human body to improve body functions and/or to replace damaged tissues. However, earlier there was no study done on biocompatibility and consequently there was no formalized approval process. Therefore, biomaterials were used only in external prosthetics and dental devices. With the emergence of biotechnology, the biomaterial market has expanded and is now playing a more important role in the medical sector. They have emerged from bio-inert materials (materials that do not react with the biological environment) to biodegradable materials. In 2008, the biomaterial market was worth $623.1 million; the market is expected to grow at a CAGR of 19.5% from 2010 to 2015. This indicates a great opportunity in the market in terms of revenues and market growth.

Biomaterial Science is the physical, chemical, and biological study of materials and their interaction with the biological environment. Biomaterial development and applications include interaction of various disciplines such as chemical engineering, mechanical engineering, biology, medical science, etc. This multi-material science uses metals, polymers, ceramics, and composites that are fabricated into medical devices and used to restore damaged tissues in the body. Biomaterials products reduce hospitalization time and help patients lead a quality life. However, risk of infection may inhibit their growth in the near future.

The briefing on the Brazil biomaterial market will benefit pharmaceutical and biotech companies, medical devices manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers and research and development companies.

Aging population (population above 60 years is expected to reach 24 million by 2012), higher life expectancy, and increase in the incidences of ‘lifestyle and chronic diseases’ such as cardiovascular diseases has influenced the growth of biomaterial products. According to the World Health Organization, 32% of the total mortality in Brazil is due to cardiovascular diseases. Such a high incidence of diseases will increase the demand for cardiovascular biomaterial products such as cardiac stents.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com

Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.